Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
December 23, 2025 |
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Professor Gareth Baynam, MBBS, DCH, FRACP, PhD, AFAIDH
Rare Care Centre
Perth Children’s Hospital
Australia
Christy Rohani-Montez, PhD
Rare Disease Education Lead
Medscape Education Global
Christy: Gareth, you’re active in so many projects in rare disease, but I want to focus on AI here. I’ve been fascinated with facial recognition tools that can be used to identify the unique facial features that are known to be associated with some 40% of rare diseases. What are your thoughts?
Gareth: Thanks, Christy. Well, one thing to consider is that all the tools at the moment are really set up as diagnostic support tools. So, they’re set up to be used together with the clinician’s knowledge and in combination with say, a genetic diagnostic to get confirmation, not as a standalone thing. That said, some of the examples, particularly for facial recognition, include GestaltMatcher, Face2Gene, and Cliniface.
Christy: And what other AI-based approaches can help shorten the rare disease diagnostic odyssey?
Gareth: There’s no doubt that generative AI approaches have really moved the needle, and there’s now almost a flood of generative AI approaches for helping to analyze genomic and other data, so I think that that’s really promising.
However, still the most useful tools we have are what we were taught in medical school: take a good history, do a good examination, listen to the person and family in front of you, and ensure continuity of care. This basic approach has become even more important today because there are amazing AI-based technologies, but the scale at which they can generate right answers and the scale at which they can generate wrong answers have both gone up.
Christy: What are the main challenges in using AI in rare disease?
Gareth: The reality is that people use lots of AI tools now to try and make diagnosis. People will be on ChatGPT or other platforms, sticking in their symptoms just like they did with Google before. But there are “hallucinations” that generative AI makes up that can sound incredibly plausible. If you’re an expert, you might have the experience to say, “Well that’s just wrong,” or “that doesn’t sound right to me.” So, it’s thinking about how to use these things responsibly. There are so many people without a diagnosis. It’s trying to serve that unmet need, but we also need to do it in a way that maximizes benefit and minimizes harm.
Christy: What AI applications do you find most exciting for rare diseases?
Gareth: Where I think there are potentially more scalable solutions that will help across the whole rare disease experience is using AI to better plan care across the lifespan. Through the International Rare Disease Research Consortium (IRDiRC), we wrote a framework on this. We’ve shifted a lot of our focus to using AI to create personalized care plans for people across the entire lived experience including health, education, and disability service provision. We call this a cross-sector approach to care. This is really important because there are 10,000 different rare disorders, so how would you expect a clinician to suddenly be able to generate a care plan on a particular condition for a child of a specific age with X,Y, Z features? And that’s what we’re increasingly able to tackle with UTOPIA. UTOPIA is an acronym for Unlocking Treatment Options Personalized In-Time Access.
Christy: Tell me more about UTOPIA.
Gareth: Well, it’s about putting accurate information into the hands of clinicians in a faster way. Instead of having to take hours searching, we can generate that information from trustworthy sources using AI. That is then available for the clinician ahead of seeing the patient and family so they can work in a more informed, efficient, and personalized way together with the patient and family and then present that information in a way that is easier to understand and use. And a core principle of UTOPIA is to ensure that solutions are equitable and globally accessible, adapting to diverse environments and peoples. It is certainly not perfect, and we strive to continually improve the approach. We are always on the outlook for people with the time and talent to help.
The below diagram shows how features of a particular disease typically evolve over time [middle of the diagram]. UTOPIA puts information together by combining the power of the patient and family voice, the expertise of the clinicians, trustworthy sources of knowledge like medical publications and various other information sources, and AI. UTOPIA uses this to create computational natural histories of disease. It connects knowledge on a condition and an individual’s disease features at different points in time and how features evolve over time (temporal phenotypes). And this is linked through to their (functional) consequences, meaning how individuals are affected or are likely to be affected in terms of function. This combination is then used to plan care across multiple sectors including health, disability, education—so a cross-sector approach for coordinated care.
Christy: That sounds like it can really make a difference for rare disease patients and families. Thank you so much for the conversation, Gareth!
References
- https://www.sciencedirect.com/science/article/abs/pii/S0002929725001351
- https://globalrarediseasecommission.com/utopia-innovative-digital-ai-platform-improves-care-for-children-with-diagnosed-and-undiagnosed-rare-diseases/
- https://www.sciencedirect.com/science/article/pii/S2950008724000401
For more information, please contact Christy Rohani Montez PHD –
srohani@medscape.net
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Evaluating the Forces Shaping Women’s Healthcare
Gaps in women’s healthcare go beyond access and cost. Do clinicians have the tools they need to understand women’s health?
Shortening the Journey at the Unusual Suspects Meeting
Medscape will be continuing their mission to shorten the diagnostic journey for patients with a rare disease at this year’s Unusual Suspects event on February 21.The Unusual Suspects is an...
Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series
What are some of the biggest gaps that women face in healthcare today? “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....
Have you heard from her?
We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...
Medscape Education Leads the Industry into New Era of Precision Education with Guaranteed Impact
NEWARK, N.J., Feb. 8, 2024 /PRNewswire/ -- Medscape Education has just unveiled its pioneering approach to developing and delivering medical education designed to drive guaranteed reach, precision targeting, and impact during this...
Hitting Every Beat—The Power of Education in Heart Failure
Heart failure can be a challenge to manage both for clinicians and patients. It’s a complex condition with various manifestations and presentations, and different disease stages that require different approaches...
Medscape Education Wins Best Practice in Advancing Diversity, Equity, and Inclusion in Medical Education at the 19th Annual NAMEC Best Practice Awards
Medscape Education was a co-recipient of the inaugural Best Practice in Advancing Diversity, Equity, and Inclusion in Medical Education award at the 19th Annual NAMEC Best Practice Awards!Creating education that...
Advancing Patient-Centered Cancer Care Through Education to #CloseTheCareGap
One of the next frontiers in oncology isn’t being explored in a lab. Instead, it’s advancing in hospitals and private clinics around the world, thanks to the hard work of...
Medscape Education’s Dedication to Delivering Impact to be Highlighted at Alliance Annual Meeting 2024
Being an active part of the continuing medical education community is a top priority for the Medscape Education team. As part of their commitment to sharing their insights and learnings...